Relationship Between Pretreatment Body Composition and Clinical Outcomes in Patients With Metastatic Renal Cell Carcinoma Receiving First-Line Ipilimumab Plus Nivolumab

CONCLUSIONS: Low SMI and low SATI were associated with significantly better PFS for patients with mRCC receiving first-line ipi/nivo. Radiographic BC variables may be useful prognostic biomarkers in this setting.PMID:37271698 | DOI:10.1016/j.clgc.2023.05.006

Source: Clinical Prostate Cancer - June 4, 2023 Category: Cancer & Oncology Authors: Hannah D McManus Dylan Zhang Fides R Schwartz Yuan Wu Jordan Infield Ethan Ho Andrew J Armstrong Daniel J George Danielle Kruse Rajan T Gupta Michael R Harrison Source Type: research